Business Description
Molecular Partners AG
ISIN : US60853G1067
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 51.96 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 2.49 | |||||
Beneish M-Score | 0.63 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.9 | |||||
3-Year EBITDA Growth Rate | 8.7 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | -14.1 | |||||
3-Year Book Growth Rate | 13.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.45 | |||||
9-Day RSI | 49.37 | |||||
14-Day RSI | 48.69 | |||||
6-1 Month Momentum % | -12.04 | |||||
12-1 Month Momentum % | -44.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.68 | |||||
Quick Ratio | 14.68 | |||||
Cash Ratio | 14.18 | |||||
Days Sales Outstanding | 92.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | 1.07 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -919.98 | |||||
Net Margin % | -870.22 | |||||
FCF Margin % | -896.61 | |||||
ROE % | -30.19 | |||||
ROA % | -27.17 | |||||
ROIC % | -515.85 | |||||
ROC (Joel Greenblatt) % | -975.67 | |||||
ROCE % | -29.11 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 16.62 | |||||
PB Ratio | 0.66 | |||||
Price-to-Tangible-Book | 0.66 | |||||
EV-to-EBIT | 1.01 | |||||
EV-to-EBITDA | 1.06 | |||||
EV-to-Revenue | -8.82 | |||||
EV-to-FCF | 0.98 | |||||
Price-to-Projected-FCF | 2 | |||||
Price-to-Net-Current-Asset-Value | 0.68 | |||||
Price-to-Net-Cash | 0.71 | |||||
Earnings Yield (Greenblatt) % | 99.01 | |||||
FCF Yield % | -54.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Molecular Partners AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 7.001 | ||
EPS (TTM) (€) | -1.855 | ||
Beta | 0 | ||
Volatility % | 39.6 | ||
14-Day RSI | 48.69 | ||
14-Day ATR (€) | 0.210868 | ||
20-Day SMA (€) | 3.302 | ||
12-1 Month Momentum % | -44.46 | ||
52-Week Range (€) | 2.36 - 6.3 | ||
Shares Outstanding (Mil) | 32.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Molecular Partners AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Molecular Partners AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Molecular Partners AG Frequently Asked Questions
What is Molecular Partners AG(STU:6ML0)'s stock price today?
When is next earnings date of Molecular Partners AG(STU:6ML0)?
Does Molecular Partners AG(STU:6ML0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |